...
首页> 外文期刊>Journal of spectroscopy >Development and Validation of UV-Visible Spectrophotometric Baseline Manipulation Method for Simultaneous Quantitation of Tenofovir Disoproxil Fumarate and Emtricitabine in Pharmaceutical Dosage Form
【24h】

Development and Validation of UV-Visible Spectrophotometric Baseline Manipulation Method for Simultaneous Quantitation of Tenofovir Disoproxil Fumarate and Emtricitabine in Pharmaceutical Dosage Form

机译:紫外-可见分光光度法基线测定同时测定药物剂量形式富马酸替诺福韦酯和恩曲他滨的方法的建立和验证

获取原文

摘要

A simple, economical, precise, and accurate new UV-visible spectrophotometric baseline manipulation method for simultaneous determination of tenofovir disoproxil fumarate (TE) and emtricitabine (EM) in combined tablet dosage form has been developed. The method is based on baseline manipulation (difference) spectroscopy where amplitudes at 261 and 289.9 nm were selected to determine TE and EM, respectively, in combined formulation, and distilled water was used as solvent. Both drugs obey Beer’s law in the concentration ranges of 4–20 μg/mL for TE and 6–30 μg/mL for EM. The results of analysis have been validated statistically, and recovery studies confirmed the accuracy of the proposed method which was carried out by following the ICH guidelines.
机译:开发了一种简单,经济,精确和准确的新型紫外可见分光光度基线操作方法,用于同时测定组合片剂剂型中的替诺福韦富马酸替诺福韦(TE)和恩曲他滨(EM)。该方法基于基线操作(差)光谱法,其中在组合配方中分别选择261和289.9 nm处的振幅以确定TE和EM,并将蒸馏水用作溶剂。两种药物都遵循比尔定律,TE的浓度范围为4-20μg/ mL,EM的浓度范围为6-30μg/ mL。分析的结果已经过统计学验证,回收率研究证实了所提出方法的准确性,该方法遵循ICH指南进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号